Saturday, July 25, 2026

biotech · Major Depressive Disorder · Schizophrenia · NBIX

NEUROCRINE BIOSCIENCES

NEUROCRINE BIOSCIENCES trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.

6027 Edgewood Bend Ct, San Diego, California 92130, US HQ
1992 Founded
2,307 Employees
Public company Type
NBIX · NYSE Ticker
Company details
Status
Public
HQ
6027 Edgewood Bend Ct, San Diego, California 92130, US
Founded
1992
Employees
2,307
Programs
5
Drugs
16
Patents
27
Intelligence · Clinical Trials

NEUROCRINE BIOSCIENCES clinical trials

Registry index of 13 ClinicalTrials.gov studies linked to NEUROCRINE BIOSCIENCES programs — each row shows trial ID, program name, phase, status, and indication.

NEUROCRINE BIOSCIENCES trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

5 updates

Latest clinical program signals indexed for NEUROCRINE BIOSCIENCES.

  1. NBI-98854-ATS3019 — Phase 3

    Clinical update
  2. Placebo — Phase 3

    Clinical update
  3. NBI-1117568 — Phase 3

    Clinical update
  4. Luvadaxistat — Phase 2

    Clinical update
  5. Valbenazine — Approved

    Clinical update

Trial registry

13 studies